Analysts: Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

6,510JPY
25 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
¥6,510
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
218,588
52-wk High
¥7,130
52-wk Low
¥4,065

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 25 Dec 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 5 5 5 5
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 1 38,100.00 38,100.00 38,100.00 --
Quarter Ending Mar-15 1 50,068.00 50,068.00 50,068.00 --
Year Ending Mar-14 9 144,644.00 149,100.00 139,500.00 --
Year Ending Mar-15 10 159,160.00 177,200.00 154,800.00 149,255.00
Year Ending Mar-16 10 178,710.00 184,800.00 164,400.00 159,740.00
Earnings (per share)
Year Ending Mar-14 10 221.41 242.29 207.24 --
Year Ending Mar-15 12 255.39 333.00 231.30 236.72
Year Ending Mar-16 12 322.80 353.60 284.47 265.46
LT Growth Rate (%) 2 17.50 20.60 14.40 13.07

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 37,050.00 38,243.00 1,193.00 3.22
Quarter Ending Jun-14 34,300.00 33,682.00 618.00 1.80
Quarter Ending Mar-14 39,854.00 39,717.00 137.00 0.34
Quarter Ending Dec-13 36,850.00 39,683.00 2,833.00 7.69
Quarter Ending Jun-13 32,750.00 34,314.00 1,564.00 4.78

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 38,100.00 38,100.00 38,100.00 38,100.00 --
Quarter Ending Mar-15 50,068.00 50,068.00 50,068.00 50,068.00 --
Year Ending Mar-14 144,644.00 -- -- -- --
Year Ending Mar-15 159,160.00 159,160.00 157,164.00 157,136.00 149,255.00
Year Ending Mar-16 178,710.00 178,710.00 178,336.00 178,636.00 159,740.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 0 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Mar-14 -- -- -- --
Year Ending Mar-15 0 0 0 0
Year Ending Mar-16 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks